Research

ABK Biomedical is a unique Y90 microspheres and bland embolic microspheres company. Our proprietary Eye90 microspheres® and Easi-Vue™ microspheres are produced at our Halifax, Nova Scotia manufacturing facility.

Click the images below to check out our state of the art manufacturing facility in more detail.

MURR

ABK Hot Cell at MURR

In February 2019, ABK Biomedical announced a new multi-year strategic partnership with the University of Missouri Research Reactor Center (MURR®).  Operating at 10-megawatts, MURR is the most powerful university research reactor in the United States.

Eye90 microspheres® in development are produced in our state of the art hot cell at MURR as part of the product development process.

The customized hot cell provides protection from dangerous radioactive isotopes, enabling a safe production and processing environment.

Perspectives

Perspectives

Potential Benefits of Radiopaque Microspheres

Bob Abraham, MD, CMO at ABK Biomedical was recently interviewed by Interventional News at The SPECTRUM Conference. Dr Abraham discussed the potential of ABK Biomedical’s radiopaque microspheres to map absorbed  radiation dose.

Click the link on the left for Dr Abraham’s perspective on this exciting advance in microsphere technology.

Products

Products

CBCT, Porcine Renal Injection, Eye90 Microspheres®

Radiopaque Y90 Microspheres for The Treatment of Hepatic Tumors

ABK Biomedical’s most advanced microspheres product in development is Eye90 Microspheres®.  Eye90 microspheres® is a breakthrough technology for radioembolization made with a proprietary, radiopaque glass composition for procedure visualization via fluoroscopy, x-ray, CT and Cone Beam CT imaging modalities. 

Eye90 Microspheres®: An advanced new therapy designed to improve the placement precision of Y90 microspheres, with the potential to provide in-procedure prognostic dosimetry for cutting-edge treatment of liver tumors.

ABK Biomedical Inc. is a Pre-clinical stage company engaged in active research and development of new medical devices. ABK products are considered investigational only and are not FDA cleared for use.

Triscaryl gelatin microspheres (left) versus Easi-Vue™ embolization microspheres (right)

Radiopaque Microspheres for Bland Embolization

ABK Biomedical’s unique bland embolic product is Easi-Vue™, a tailored radiopaque permanent embolization microsphere. Easi-Vue embolization microspheres are being developed in a range of microsphere sizes that are inherently radiopaque for direct visualization of the embolic at the target site​ during embolotherapy.  

ABK Biomedical Inc. is a Pre-clinical stage company engaged in active research and development of new medical devices. ABK products are considered investigational only and are not FDA cleared for use.

Scientific Research

Scientific Research

Radiopaque Microspheres Presentation

Bob Abraham, MD, CMO at ABK Medical regularly presents the latest advances in radioembolization at major international meetings including presentations at the SIR and GEST Annual Meetings in 2019.

*GEST 2019 reflecting updated datapoints February 2020.

Biomedical Physics & Engineering Express – August 2019

ABK Biomedical and collaborators from Dalhousie University and MD Anderson Cancer Center in Houston recently published a paper entitled Quantification of the inherent radiopacity of glass microspheres for precision dosimetry in yttrium-90 radioembolization.

Click the link on the left to view and download the abstract for this peer reviewed publication

Corporate Offices

Halifax Office (Main Office)
155 Chain Lake Drive
Unit 32
Halifax, NS B3S 1B3
Canada
E. 
info@abkbiomedical.com
T. 902.442.4009

 

Orange County Office
555 Corporate Drive 
Suite 105
Ladera Ranch, CA, 92694
USA
E. 
info@abkbiomedical.com

ABK Biomedical Inc. provides and continues to provide accurate information on its website. However, ABK Biomedical Inc. assumes no responsibility for accuracy and/or completeness, express or implied, as to the information contained or omitted and/or the products described. Furthermore, ABK Biomedical may change the products mentioned at any time without notice. ABK Biomedical Inc. is a Pre-clinical stage company engaged in the active research and development of new medical devices. ABK Biomedical products are considered investigational only and are not FDA cleared for use..

(C) Copyright 2019 – All International Rights Reserved – ABK Biomedical Inc.